279 related articles for article (PubMed ID: 9664234)
21. An overview of rodent toxicities: liver and kidney effects of fumonisins and Fusarium moniliforme.
Voss KA; Riley RT; Norred WP; Bacon CW; Meredith FI; Howard PC; Plattner RD; Collins TF; Hansen DK; Porter JK
Environ Health Perspect; 2001 May; 109 Suppl 2(Suppl 2):259-66. PubMed ID: 11359694
[TBL] [Abstract][Full Text] [Related]
22. Elevated sphingoid bases and complex sphingolipid depletion as contributing factors in fumonisin-induced cytotoxicity.
Yoo HS; Norred WP; Showker J; Riley RT
Toxicol Appl Pharmacol; 1996 Jun; 138(2):211-8. PubMed ID: 8658522
[TBL] [Abstract][Full Text] [Related]
23. Induction of apoptosis by fumonisin B1 in HT29 cells is mediated by the accumulation of endogenous free sphingoid bases.
Schmelz EM; Dombrink-Kurtzman MA; Roberts PC; Kozutsumi Y; Kawasaki T; Merrill AH
Toxicol Appl Pharmacol; 1998 Feb; 148(2):252-60. PubMed ID: 9473533
[TBL] [Abstract][Full Text] [Related]
24. Fumonisin B1 induces apoptosis in cultured human keratinocytes through sphinganine accumulation and ceramide depletion.
Tolleson WH; Couch LH; Melchior WB; Jenkins GR; Muskhelishvili M; Muskhelishvili L; McGarrity LJ; Domon O; Morris SM; Howard PC
Int J Oncol; 1999 May; 14(5):833-43. PubMed ID: 10200332
[TBL] [Abstract][Full Text] [Related]
25. Silymarin protects against liver damage in BALB/c mice exposed to fumonisin B1 despite increasing accumulation of free sphingoid bases.
He Q; Kim J; Sharma RP
Toxicol Sci; 2004 Aug; 80(2):335-42. PubMed ID: 15103051
[TBL] [Abstract][Full Text] [Related]
26. Fumonisin B(1) induces apoptosis in LLC-PK(1) renal epithelial cells via a sphinganine- and calmodulin-dependent pathway.
Kim MS; Lee DY; Wang T; Schroeder JJ
Toxicol Appl Pharmacol; 2001 Oct; 176(2):118-26. PubMed ID: 11601888
[TBL] [Abstract][Full Text] [Related]
27. Disruption of sphingolipid metabolism in non-human primates consuming diets of fumonisin-containing Fusarium moniliforme culture material.
Shephard GS; van der Westhuizen L; Thiel PG; Gelderblom WC; Marasas WF; van Schalkwyk DJ
Toxicon; 1996 May; 34(5):527-34. PubMed ID: 8783447
[TBL] [Abstract][Full Text] [Related]
28. Sphingoid bases and their phosphates: transient activation and delayed repression of protein kinase C isoforms and their possible involvement in fumonisin B1 cytotoxicity.
Gopee NV; Sharma RP
Toxicology; 2003 May; 187(2-3):239-50. PubMed ID: 12699912
[TBL] [Abstract][Full Text] [Related]
29. Toxicity of Fusarium moniliforme culture material containing known levels of fumonisin B1 in ducks.
Bailly JD; Benard G; Jouglar JY; Durand S; Guerre P
Toxicology; 2001 May; 163(1):11-22. PubMed ID: 11376861
[TBL] [Abstract][Full Text] [Related]
30. Tolerance to fumonisin toxicity in a mouse strain lacking the P75 tumor necrosis factor receptor.
Sharma RP; Bhandari N; Riley RT; Voss KA; Meredith FI
Toxicology; 2000 Feb; 143(2):183-94. PubMed ID: 10755704
[TBL] [Abstract][Full Text] [Related]
31. Characterization of cell-cycle arrest by fumonisin B1 in CV-1 cells.
Ciacci-Zanella JR; Merrill AH; Wang E; Jones C
Food Chem Toxicol; 1998; 36(9-10):791-804. PubMed ID: 9737426
[TBL] [Abstract][Full Text] [Related]
32. Fumonisin hepatotoxicity is reduced in mice carrying the human tumour necrosis factor alpha transgene.
Sharma RP; Bhandari N; Tsunoda M; Riley RT; Voss KA
Arch Toxicol; 2000 Jul; 74(4-5):238-48. PubMed ID: 10959799
[TBL] [Abstract][Full Text] [Related]
33. Sphingosine kinase activity confers resistance to apoptosis by fumonisin B1 in human embryonic kidney (HEK-293) cells.
Sharma N; He Q; Sharma RP
Chem Biol Interact; 2004 Dec; 151(1):33-42. PubMed ID: 15607760
[TBL] [Abstract][Full Text] [Related]
34. Fumonisin B1-induced increases in neurotransmitter metabolite levels in different brain regions of BALB/c mice.
Tsunoda M; Dugyala RR; Sharma RP
Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1998 Oct; 120(3):457-65. PubMed ID: 9827064
[TBL] [Abstract][Full Text] [Related]
35. Fumonisin toxicity and metabolism studies at the USDA. Fumonisin toxicity and metabolism.
Norred WP; Voss KA; Riley RT; Plattner RD
Adv Exp Med Biol; 1996; 392():225-36. PubMed ID: 8850620
[TBL] [Abstract][Full Text] [Related]
36. Tumor necrosis factor-alpha as a contributor in fumonisin B1 toxicity.
Dugyala RR; Sharma RP; Tsunoda M; Riley RT
J Pharmacol Exp Ther; 1998 Apr; 285(1):317-24. PubMed ID: 9536027
[TBL] [Abstract][Full Text] [Related]
37. Renal effects of fumonisin mycotoxins in animals.
Bucci TJ; Howard PC; Tolleson WH; Laborde JB; Hansen DK
Toxicol Pathol; 1998; 26(1):160-4. PubMed ID: 9502399
[TBL] [Abstract][Full Text] [Related]
38. Persistence and reversibility of the elevation in free sphingoid bases induced by fumonisin inhibition of ceramide synthase.
Enongene EN; Sharma RP; Bhandari N; Miller JD; Meredith FI; Voss KA; Riley RT
Toxicol Sci; 2002 Jun; 67(2):173-81. PubMed ID: 12011476
[TBL] [Abstract][Full Text] [Related]
39. Studies on the reproductive effects of Fusarium moniliforme culture material in rats and the biodistribution of [14C] fumonisin B1 in pregnant rats.
Voss KA; Bacon CW; Norred WP; Chapin RE; Chamberlain WJ; Plattner RD; Meredith FI
Nat Toxins; 1996; 4(1):24-33. PubMed ID: 8680750
[TBL] [Abstract][Full Text] [Related]
40. Dietary fumonisins disrupt sphingolipid metabolism in mink and increase the free sphinganine to sphingosine ratio in urine but not in hair.
Morgan MK; Schroeder JJ; Rottinghaus GE; Powell DC; Bursian SJ; Aulerich RJ
Vet Hum Toxicol; 1997 Dec; 39(6):334-6. PubMed ID: 9397500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
